ScholarIQanswers from OpenAlex

Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer

PaperCitations, authors & open-access status

Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer have?

ScholarIQcitation count

Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer has 313 citations in the OpenAlex counts ScholarIQ stores.

When was Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer published?

ScholarIQyear

Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer has 1999 year in the ScholarIQ index.

What is the open-access status of Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer?

ScholarIQoa status

Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer has closed oa status in the ScholarIQ index.

What is the DOI of Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer?

ScholarIQdoi

The DOI for Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer is on the source record.

What is the PMID of Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer?

ScholarIQpmid

The PMID for Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer is on the source record.

What is the OpenAlex record for Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer?

ScholarIQopenalex

The OpenAlex for Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial